David C. Sachs insider trades

Open-market stock purchases and sales by David C. Sachs, Chief Financial Officer at ImmunityBio, Inc, from SEC Form 4 filings since Sep 9, 2021.

Recent trades

DateStockTradeValue
Feb 22, 2026IBRX ImmunityBio, IncSold (not open market)$180K
Feb 22, 2026IBRX ImmunityBio, IncBought (not open market)—
Feb 10, 2026IBRX ImmunityBio, IncSold (not open market)$296K
Feb 10, 2026IBRX ImmunityBio, IncBought (not open market)—
Dec 31, 2025IBRX ImmunityBio, IncSold (not open market)$30.6K
Dec 31, 2025IBRX ImmunityBio, IncBought (not open market)—

Companies traded

  • IBRX ImmunityBio, Inc: other filings, last Feb 22, 2026

Get free alerts when David C. Sachs files a new trade →